India's stock market shows strong resilience amid global trade tensions, with robust sectoral gains and outperforming global peers, driven by solid fundamentals and a favorable macroeconomic outlook.

The Ministry of Commerce and Industry will allocate a significant portion of the second Rs. 10,000 crore (US$ 1.16 billion) Fund of Funds Scheme to support budding entrepreneurs.

Driven by rising disposable incomes and disciplined investing, monthly Systematic Investment Plan inflows in India's mutual fund industry are expected to reach US$ 4.65 billion within 18–24 months.

India's seafood exporters are set to ship 35,000-40,000 tonnes of shrimp to the United States after a temporary tariff reduction, offering relief for delayed shipments.

India’s luxury housing market sustained its upward trajectory in Q1 2025, with sales of high-end homes priced above US$ 464,594.80 rising nearly 28% YoY across the top seven cities.

India's semiconductor end-demand revenues are projected to double by 2030, while localisation opportunities are expected to contribute around US$ 13 billion.

India's hospitality industry is set for rapid growth, with over 1,00,000 new rooms expected in the next five years, marking a 20-30% increase from 2024.

India is fast becoming a global electronics manufacturing hub with rising value addition and soaring mobile exports, supported by policy reforms and reduced imports of finished goods.

Indian airport operators are set to witness 18–20% growth in FY26, driven by rising passenger traffic, tariff hikes, and higher non-aeronautical revenues, says ICRA.

President of India, Ms. Droupadi Murmu, invited Slovakian businesses to join “Make in India,” emphasising India’s economic ambitions and its role as a stable growth partner globally.

JioHotstar has become the world's third-largest video streaming service with over 200 million paid subscribers, driven by its multi-language live IPL coverage.

India’s pharmaceutical market grew 8.4% in FY25, led by strong value growth in cardiac, gastrointestinal, and anti-diabetic therapies, according to Pharmarack.